Related content

Selective Axillary Surgery in Breast Cancer Patients Based on Positron Emission Tomography with ^18F-Fluoro-2-Deoxy-D-Glucose: not Yet!

By Guller U.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 2, 2002-01 ,pp. : 171-173

Springer Publishing Company

Access to resources Recommend Favorite

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Diagnosis of Recurrent Ovarian Cancer

By Zimny M.   Siggelkow W.   Schroder W.   Nowak B.   Biemann S.   Rath W.   Buell U.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 310-315

Elsevier

Access to resources Recommend Favorite

Feasibility of Detecting Hypoxia in Experimental Mouse Tumours with ¹⁸F-fluorinated Tracers and Positron Emission Tomography: A Study Evaluating [¹⁸F]Fluoromisonidazole and [¹⁸F]Fluoro-2-deoxy-D-glucose

By Bentzen Lise   Keiding Susanne   Horsman Michael R.   Falborg Lise   Hansen Søren B.   Overgaard Jens  

Acta Oncologica, Vol. 39, Iss. 5, 2000-10 ,pp. : 629-637

Informa Healthcare

Access to resources Recommend Favorite

Measurement of clinical and subclinical tumour response using [ 18 F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations - reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-d-glucose uptake at PET

By Young H.   Baum R.   Cremerius U.   Herholz K.   Hoekstra O.   Lammertsma A.A.   Pruim J.   Price P.  

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1773-1782

Elsevier

Access to resources Recommend Favorite

Predictive impact of 2- 18 fluoro-2-deoxy-d-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. de santis m., bokemeyer c., becherer a., et al. - J of clin onc (2001) 19:3740-3744

By Rowland R.G.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 1, 2003-01 ,pp. : 89-89

Elsevier

Access to resources Recommend Favorite